Expert Call: Follow Ups: KOL Call on Oncology Space

Research evidence excerpt

Expert Call: Follow Ups: KOL Call on Oncology Space

Deutsche Bank

Research

North America Industry Date

United States 26 June 2026

Expert Call

Health Care Others

Healthcare Technology &

Distribution

Follow Ups: KOL Call on Oncology

Space

George Hill

Round Two - Deep Dive into Oncology MSO: The community oncology space has

Research Analyst

been a highly attractive end market for the big three drug distributors. As part of our +1-212-250-7822

research series in the community oncology space, we hosted a very informative

webinar a couple weeks ago with the CEO of Pontchartrain Cancer Center, who Maxi Ma, CFA

Research Associate

shared many details on practice level economics and wholesaler competitive

+1-901-338-2175

dynamics. Key takeaways from this call can be viewed through this link: Drug

Supply Chain: Bayou Briefing: Oncology KOL Call Recap. We are hosting a follow- Liz Li

up call with her on Tuesday, June 30 at 11am ET to cover topics we didn’t get to Research Associate

touch on due to time constraints last time, including more deep dives in the recent +1-617-251-2782

industry trends, impacts from policy changes, market consolidation, drug

procurement, and oncology MSO's strategic fit with major drug distributors.

Speaker’s Bio: Kathy Oubre has been serving as the CEO of Pontchartrain Cancer

Center in Louisiana since 2018. Prior to this role, she worked as the COO at

Pontchartrain for eight years. She is a board member of the Community Oncology

Alliance, co-chairs the Drug Policy and Regulatory Affairs committee, and serves on

their Government Affairs committee. She also serves on the Strategic Advisory

Committee and Leadership Council for Flatiron Health and is on the Executive Board

for Athena Oncology. She is also a co-chair of the Association of Value-Based